DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,372 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $29,317,000 | -13.4% | 99,944 | -2.9% | 0.84% | +2.7% |
Q4 2021 | $33,862,000 | +1.9% | 102,920 | -5.7% | 0.81% | +9.7% |
Q3 2021 | $33,239,000 | +11.6% | 109,182 | -1.6% | 0.74% | +11.1% |
Q2 2021 | $29,791,000 | +10.2% | 111,011 | -7.6% | 0.67% | +3.4% |
Q1 2021 | $27,028,000 | -14.9% | 120,081 | -16.0% | 0.64% | -18.0% |
Q4 2020 | $31,767,000 | +1.0% | 143,005 | -2.1% | 0.79% | -10.1% |
Q3 2020 | $31,464,000 | +16.5% | 146,119 | -4.3% | 0.88% | +11.0% |
Q2 2020 | $27,012,000 | +34.1% | 152,759 | +5.0% | 0.79% | +13.1% |
Q1 2020 | $20,145,000 | -11.9% | 145,549 | -2.3% | 0.70% | +11.5% |
Q4 2019 | $22,855,000 | -1.3% | 148,910 | -7.1% | 0.62% | -5.0% |
Q3 2019 | $23,158,000 | -4.2% | 160,338 | -5.2% | 0.66% | -0.6% |
Q2 2019 | $24,171,000 | +2.6% | 169,126 | -5.2% | 0.66% | -9.4% |
Q1 2019 | $23,563,000 | +29.6% | 178,484 | +1.2% | 0.73% | +15.8% |
Q4 2018 | $18,185,000 | -5.1% | 176,358 | -0.1% | 0.63% | +6.4% |
Q3 2018 | $19,167,000 | +10.0% | 176,506 | -0.1% | 0.59% | +32.4% |
Q2 2018 | $17,427,000 | +2.3% | 176,603 | +1.5% | 0.45% | -17.0% |
Q1 2018 | $17,038,000 | +7.4% | 174,017 | +1.8% | 0.54% | +9.1% |
Q4 2017 | $15,870,000 | +10.7% | 170,982 | +2.4% | 0.50% | +3.3% |
Q3 2017 | $14,330,000 | +5.9% | 167,049 | +4.1% | 0.48% | +4.4% |
Q2 2017 | $13,535,000 | +8.1% | 160,394 | +9.6% | 0.46% | +5.0% |
Q1 2017 | $12,520,000 | +11.8% | 146,372 | +1.7% | 0.44% | +5.6% |
Q4 2016 | $11,200,000 | +1.6% | 143,880 | +2.3% | 0.41% | -28.6% |
Q3 2016 | $11,025,000 | -16.9% | 140,633 | +7.1% | 0.58% | -18.4% |
Q2 2016 | $13,261,000 | +7.2% | 131,308 | +0.7% | 0.71% | +8.4% |
Q1 2016 | $12,372,000 | +5.2% | 130,426 | +3.0% | 0.66% | +5.5% |
Q4 2015 | $11,759,000 | +13.9% | 126,605 | +4.5% | 0.62% | +6.3% |
Q3 2015 | $10,328,000 | +19.8% | 121,205 | +20.4% | 0.58% | +28.9% |
Q2 2015 | $8,618,000 | +64.5% | 100,692 | +63.2% | 0.45% | +70.7% |
Q1 2015 | $5,238,000 | -1.2% | 61,694 | -0.2% | 0.27% | -1.5% |
Q4 2014 | $5,301,000 | +12.7% | 61,843 | -0.1% | 0.27% | +8.4% |
Q3 2014 | $4,702,000 | -0.5% | 61,887 | +3.0% | 0.25% | -1.2% |
Q2 2014 | $4,728,000 | +100.2% | 60,060 | +90.7% | 0.25% | +78.7% |
Q1 2014 | $2,362,000 | -6.0% | 31,489 | -3.2% | 0.14% | -2.1% |
Q4 2013 | $2,512,000 | +20.4% | 32,537 | +8.1% | 0.14% | +9.1% |
Q3 2013 | $2,087,000 | +10.0% | 30,099 | +0.5% | 0.13% | +7.3% |
Q2 2013 | $1,897,000 | – | 29,959 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |